MeSH tree: C14.280.238
A Penn Medicine–led team has developed a first-of-its-kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians. Trained on more than 300,000 MRI video clips from ...
Mar 25, 2026
0
2
Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally intended, but by retraining ...
Feb 27, 2026
0
22
A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat, as well as possible clues to future treatment of devastating heart ailments. Washington State University researchers have found ...
Feb 26, 2026
0
3
Postpartum experiences are as unique as the pregnancies that come before them. Because of this, it can be difficult to recognize what's normal and what could be a complication—even if you've given birth before.
Feb 21, 2026
0
11
For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar brand names. However, ...
Feb 20, 2026
0
7
Scientists at Université de Montréal and its affiliated Centre de recherche Azrieli du CHU Sainte-Justine have made a major advance in their research into cardiovascular disease: They've created functional, three-dimensional ...
Feb 3, 2026
0
16
The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the finding of a new study from Uppsala University that mapped all cases of cardiomyopathy in Sweden. Despite ...
Jan 31, 2026
0
10
Though rare, sudden cardiac arrest (SCA) in athletes often unfolds in high-visibility settings, like sports arenas, prompting questions about underlying causes, emergency preparedness, and long-term outcomes. A new review ...
Jan 15, 2026
0
116
Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that protects the heart during pregnancy, shedding new light on the causes of peripartum cardiomyopathy ...
Jan 12, 2026
0
8
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to Cytokinetics.
Jan 6, 2026
0
18
